drugset / Trial / NCT06220773
A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this clinical study is to Evaluate the Efficacy and Safety of BR1019A and BR1019B combination therapy in Patients with Essential Hypertension and Type 2 Diabetes Mellitus
Timeline
- Start
- 2024-05-21
- Primary completion
- 2025-04
- Completion
- 2025-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR1019A | Unknown | — | — |
| Subject | BR1019A-1 | Unknown | — | — |
| Subject | BR1019B | Unknown | — | — |
| Comparator | BR1019B-1 | Unknown | — | — |
| Subject | BR1019C | Unknown | — | — |
| Subject | BR1019C-1 | Unknown | — | — |